VolitionRX News

VolitionRX Analyst Ratings

BenzingaMar 27 09:37 ET

Benchmark Co. Sticks to Its Hold Rating for VolitionRX (VNRX)

TipRanksMar 27 08:26 ET

Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)

TipRanksJan 3 07:23 ET

VolitionRX Analyst Ratings

BenzingaJan 2 13:33 ET

VolitionRX Analyst Ratings

BenzingaNov 21, 2023 14:11 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS), Madrigal Pharmaceuticals (MDGL) and VolitionRX (VNRX)

TipRanksNov 20, 2023 08:33 ET

Cantor Fitzgerald Maintains Overweight on VolitionRX, Raises Price Target to $2.5

BenzingaNov 16, 2023 09:31 ET

VolitionRX Analyst Ratings

BenzingaNov 16, 2023 09:30 ET

EF Hutton Initiates Coverage On VolitionRX With Buy Rating, Announces Price Target of $4.5

BenzingaOct 30, 2023 10:58 ET

VolitionRX Analyst Ratings

BenzingaOct 30, 2023 10:53 ET

Cantor Fitzgerald Reaffirms Their Buy Rating on VolitionRX (VNRX)

TipRanksOct 27, 2023 09:26 ET

Analysts Conflicted on These Healthcare Names: Bicycle Therapeutics (BCYC), Abbott Labs (ABT) and VolitionRX (VNRX)

TipRanksOct 27, 2023 07:20 ET

Maxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)

TipRanksAug 23, 2023 10:25 ET

VolitionRX Analyst Ratings

BenzingaAug 16, 2023 07:59 ET

EF Hutton Assumes VolitionRX at Buy, Announces Price Target of $6

BenzingaJun 1, 2023 04:50 ET

Maxim Group Sticks to Their Buy Rating for VolitionRX (VNRX)

TipRanksMar 21, 2023 07:56 ET

EF Hutton Keeps Their Buy Rating on VolitionRX (VNRX)

TipRanksMar 16, 2023 12:49 ET

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), VolitionRX (VNRX) and Pharming Group (PHAR)

TipRanksMar 16, 2023 12:38 ET

EF Hutton Reiterates Buy on VolitionRX, Maintains $6 Price Target

BenzingaMar 16, 2023 11:24 ET

VolitionRX Analyst Ratings

Benzinga Analyst RatingsFeb 1, 2023 07:18 ET